Exodus Point Capital Management, LP Rigel Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.67 - $11.9 $209,766 - $3.73 Million	-313,085 Reduced 88.63%	40,159 $60,000
Q3 2022 Nov 10, 2022	BUY	$1.1 - $12.2 $388,568 - $4.31 Million	353,244 New	353,244 $417,000
Q2 2022 Aug 19, 2022	SELL	$0.67 - $3.19 $280,576 - $1.34 Million	-418,771 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.22 - $3.45 $125,430 - $194,925	56,500 Added 15.6%	418,771 $1.25 Million
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $795,723 - $1.2 Million	337,171 Added 1343.31%	362,271 $960,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $87,850 - $112,950	25,100 New	25,100 $91,000
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $81,786 - $120,164	-26,468 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.35 - $4.93 $10,760 - $15,835	-3,212 Reduced 10.82%	26,468 $91,000
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $24,028 - $38,241	-10,225 Reduced 25.62%	29,680 $104,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $29,914 - $69,408	16,806 Added 72.76%	39,905 $96,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $32,569 - $47,352	23,099 New	23,099 $42,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $14,122 - $33,360	-11,120 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $17,792 - $27,021	11,120 New	11,120 $24,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $30,937 - $49,727	-18,980 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $38,339 - $49,537	18,980 New	18,980 $50,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.